TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,244,758 | +4.1% | 80,463 | +5.7% | 0.00% | – |
Q2 2023 | $1,195,696 | -0.5% | 76,110 | +4.4% | 0.00% | – |
Q1 2023 | $1,201,482 | -22.0% | 72,905 | -26.2% | 0.00% | -100.0% |
Q4 2022 | $1,541,000 | +6.3% | 98,823 | -11.6% | 0.00% | 0.0% |
Q3 2022 | $1,449,000 | +72.5% | 111,782 | +86.7% | 0.00% | – |
Q2 2022 | $840,000 | -27.3% | 59,865 | -25.8% | 0.00% | – |
Q1 2022 | $1,155,000 | +30.5% | 80,683 | +24.9% | 0.00% | – |
Q4 2021 | $885,000 | -25.8% | 64,586 | -11.4% | 0.00% | – |
Q3 2021 | $1,193,000 | +13.8% | 72,902 | +17.1% | 0.00% | – |
Q2 2021 | $1,048,000 | -6.0% | 62,265 | +2.5% | 0.00% | – |
Q1 2021 | $1,115,000 | +38.2% | 60,757 | +37.2% | 0.00% | – |
Q4 2020 | $807,000 | -22.0% | 44,275 | -23.7% | 0.00% | – |
Q3 2020 | $1,035,000 | -68.5% | 58,025 | -68.4% | 0.00% | -100.0% |
Q2 2020 | $3,288,000 | +377.9% | 183,343 | +304.2% | 0.00% | – |
Q1 2020 | $688,000 | -23.9% | 45,354 | -0.9% | 0.00% | – |
Q4 2019 | $904,000 | +6.2% | 45,784 | -7.6% | 0.00% | – |
Q3 2019 | $851,000 | -12.2% | 49,533 | -9.5% | 0.00% | – |
Q2 2019 | $969,000 | -62.0% | 54,752 | -56.2% | 0.00% | -100.0% |
Q1 2019 | $2,547,000 | +34.1% | 125,059 | +10.7% | 0.00% | 0.0% |
Q4 2018 | $1,900,000 | +258.5% | 112,990 | +342.6% | 0.00% | – |
Q4 2016 | $530,000 | +117.2% | 25,528 | +150.7% | 0.00% | – |
Q3 2016 | $244,000 | -15.6% | 10,181 | -24.1% | 0.00% | – |
Q2 2016 | $289,000 | -9.4% | 13,413 | -4.1% | 0.00% | – |
Q1 2016 | $319,000 | -26.2% | 13,985 | -18.9% | 0.00% | – |
Q4 2015 | $432,000 | +24.9% | 17,238 | +9.1% | 0.00% | – |
Q3 2015 | $346,000 | -16.4% | 15,807 | -6.4% | 0.00% | – |
Q2 2015 | $414,000 | -8.4% | 16,896 | -6.6% | 0.00% | – |
Q1 2015 | $452,000 | +31.8% | 18,088 | +10.0% | 0.00% | – |
Q4 2014 | $343,000 | +134.9% | 16,438 | +145.5% | 0.00% | – |
Q3 2014 | $146,000 | -18.9% | 6,697 | -13.7% | 0.00% | – |
Q2 2014 | $180,000 | -12.2% | 7,758 | -10.1% | 0.00% | – |
Q1 2014 | $205,000 | +1.5% | 8,633 | -1.8% | 0.00% | – |
Q4 2013 | $202,000 | +7.4% | 8,788 | +10.5% | 0.00% | – |
Q3 2013 | $188,000 | +28.8% | 7,953 | +25.6% | 0.00% | – |
Q2 2013 | $146,000 | – | 6,333 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |